Translational Treatment for Cardiovascular Disease
Where: GTRI Conference Center Auditorium, (250 14th Street, NW, Atlanta, Georgia 30318).
Free parking on site: Please use decks 3 and 4 in the parking garage adjacent to the auditorium.
Download the program here
Cardiovascular diseases are the world’s largest killers, claiming 17.1 million lives a year. Still, major progress has been made in treating these diseases, especially against chronic coronary atherosclerosis, the most common serious cardiovascular disease.
Along with plans for a close research cooperation between the University Hospital of Toulouse (Pr. Michel Galinier) and Saint-Joseph’s Research Institute in Atlanta, a research symposium about translational treatment for cardiovascular disease will be organized to bring together doctors and researchers from:
• Saint-Joseph’s Research Institute: Dr. Spencer King, Nicholas Chronos, Jack Chen, Doug Murphy, Sudir Srivastava and Jack O’Connell;
• CHU Toulouse-Rangueil Hospital: Dr. Atul Pathak, Jerôme Roncalli and Philippe Rouet;
• Clinique Pasteur at Toulouse: Dr. Jean Marco.
As a special feature of the symposium, a lunch will be prepared for the participants by the Executive Chef Roger Michel (Westin Hotel – Savannah, GA) illustrating “The French Paradox” (the idea that the French people eat foods high in fat, drink wine and rarely participate in structured exercise, yet have lower instances of obesity and heart disease than other countries).
Registration is required by November 29, 2010.
To register, please click on this link
Contact: Jacqueline Signorini, Scientific Attaché
attache-univ.mst@ambascience-usa.org
With the support of:
